Cargando…
Immune Checkpoint Inhibitors for Gastrointestinal Malignancies: An Update
SIMPLE SUMMARY: Immune checkpoint inhibitors are a class of anti-cancer therapy that work by harnessing the body’s immune system to promote cancer cell death. These drugs have become standard of care for many types of cancer, including melanoma and lung cancer, after clinical trials showed they work...
Autores principales: | DeCarli, Kathryn, Strosberg, Jonathan, Almhanna, Khaldoun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454768/ https://www.ncbi.nlm.nih.gov/pubmed/36077740 http://dx.doi.org/10.3390/cancers14174201 |
Ejemplares similares
-
Vaccines in Gastrointestinal Malignancies: From Prevention to Treatment
por: Chudasama, Rani, et al.
Publicado: (2021) -
Role of Immune Checkpoint Inhibitors in Gastrointestinal Malignancies
por: Mazloom, Anita, et al.
Publicado: (2020) -
Immune checkpoint inhibitor-mediated colitis in gastrointestinal malignancies and inflammatory bowel disease
por: Weingarden, Alexa R, et al.
Publicado: (2021) -
Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies
por: Wang, Dongxu, et al.
Publicado: (2019) -
What is the role of checkpoint inhibitors in neuroendocrine neoplasms?
por: Al-Toubah, Taymeyah, et al.
Publicado: (2020)